Response to HIV-1 gp160-carrying recombinant virus HSV-1 and HIV-1 VLP combined vaccine in BALB/c mice
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Microbiology"
DOI: 10.3389/fmicb.2023.1136664
Abstract: Human immunodeficiency virus (HIV) induced AIDS causes a large number of infections and deaths worldwide every year, still no vaccines are available to prevent infection. Recombinant herpes simplex virus type 1 (HSV-1) vector-based vaccines coding… read more here.
Keywords: balb mice; hiv; recombinant virus; hsv ... See more keywords
Detection of Neutralizing Antibodies in HIV-1 Patients on Antiretroviral Treatment for Over Ten Years.
Sign Up to like & getrecommendations! Published in 2019 at "Clinical laboratory"
DOI: 10.7754/clin.lab.2019.181240
Abstract: BACKGROUND Recently, many broadly applicable and potent neutralizing antibodies have been screened from HIV-1-infected patients. However, all these effective neutralizing antibodies were isolated from patients naive to anti-retroviral treatment (ART). METHODS To better understand the… read more here.
Keywords: antibodies hiv; ten years; treatment; detection neutralizing ... See more keywords